Stock Events

enVVeno Medical 

$1.75
0
+$0+0% Today

Statistics

Day High
0.3
Day Low
0.3
52W High
1.25
52W Low
0.21
Volume
100
Avg. Volume
1,090
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6MayExpected
Q2 2022
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Next
-0.63
-0.42
-0.21
0
Expected EPS
-0.42
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NVNBW. It's not an investment recommendation.

About

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based devices to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and works as a replacement venous valve to reduce reflux and venous hypertension, as well as to restore proper directional blood flow back to the heart. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Show more...
CEO
Mr. Robert A. Berman
Employees
19
Country
USA
ISIN
US29415J1300

Listings